Related Experiment Video
Updated: Jun 8, 2025

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
Published on: December 23, 2014
Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and
Gwo-Jyh Chang1,2, Wei-Jan Chen2, Yu-Juei Hsu3
1Graduate Institute of Clinical Medicinal Sciences Chang-Gung University College of Medicine Tao-Yuan Taiwan.
Background:
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events. However, the precise mechanisms beyond glycemic control are not fully understood. The objective of this study was to determine the role of PDGF (platelet-derived growth factor)-related signaling in empagliflozin-mediated inhibition of neointima formation.
Methods And Results:
Adult male nondiabetic Wistar rats were subjected to carotid artery balloon injury. Empagliflozin (30 mg/kg per day) was administered by oral gavage for 18 days beginning 4 days before surgery. The in vitro effects of empagliflozin on rat aortic vascular smooth muscle cell (VSMC) proliferation and migration were also determined. Empagliflozin attenuated balloon injury-induced neointima formation in carotid arteries. In VSMCs, empagliflozin attenuated PDGF-BB-induced proliferation and migration. Moreover, empagliflozin-treated VSMCs did not undergo apoptosis or cytotoxic death. Empagliflozin suppressed PDGF-related signaling, including phosphorylation of PDGF receptor β, Akt, and STAT3 (signal transducer and activator of transcription 3). Overactivation of PDGF signaling attenuated empagliflozin-mediated inhibition of VSMC function. SGLT2 mRNA levels in rat VSMCs were undetectable, and SGLT2 silencing did not alter the empagliflozin-mediated effects, supporting the SGLT2-independent effects of empagliflozin on VSMC.
Conclusions:
This study highlights the crucial role of suppressing PDGF-related signaling in mediating the beneficial effects of empagliflozin on neointima formation and VSMC function, which are independent of SGLT2 and glycemic control. Our study provides a novel mechanistic aspect of empagliflozin for the prevention of vascular stenosis disorders.
Insights
Empagliflozin inhibits neointima formation by suppressing platelet-derived growth factor (PDGF) signaling, independent of SGLT2. This mechanism offers new insights into preventing vascular stenosis disorders.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Cell Biology
Background:
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors are known to reduce cardiovascular events.
- The exact mechanisms underlying these benefits, beyond glycemic control, require further elucidation.
- Platelet-derived growth factor (PDGF)-related signaling is implicated in vascular remodeling processes.
Purpose of the Study:
- To investigate the role of PDGF-related signaling in empagliflozin's effects on neointima formation.
- To determine if empagliflozin's vascular effects are dependent on SGLT2 expression or glycemic control.
Main Methods:
- Adult male Wistar rats underwent carotid artery balloon injury.
- Empagliflozin was administered orally before and after injury.
- In vitro studies assessed empagliflozin's impact on vascular smooth muscle cell (VSMC) proliferation and migration.
- PDGF signaling pathways (PDGF receptor β, Akt, STAT3 phosphorylation) were analyzed.
Main Results:
- Empagliflozin significantly reduced neointima formation following balloon injury.
- Empagliflozin inhibited PDGF-BB-induced VSMC proliferation and migration in vitro.
- Empagliflozin suppressed PDGF-related signaling pathways.
- SGLT2 was undetectable in rat VSMCs, and its silencing did not affect empagliflozin's actions.
Conclusions:
- Empagliflozin's beneficial effects on neointima formation and VSMC function are mediated by suppressing PDGF-related signaling.
- These vascular protective effects are independent of SGLT2 and glycemic control.
- This study reveals a novel mechanism for empagliflozin in preventing vascular stenosis.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...

